1-4 of 4
Authors: Hervé Fleury
Journal Article
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 6, June 2010, Pages 1262–1269, https://doi.org/10.1093/jac/dkq099
Published: 12 April 2010
Journal Article
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 3, March 2010, Pages 434–437, https://doi.org/10.1093/jac/dkp473
Published: 05 January 2010
Journal Article
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort Get access
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 6, June 2009, Pages 1251–1255, https://doi.org/10.1093/jac/dkp114
Published: 31 March 2009
Journal Article
Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study) Get access
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 5, November 2006, Pages 1090–1093, https://doi.org/10.1093/jac/dkl348
Published: 18 August 2006
